master's thesis
Značajke liječenja interferonom beta 1a i 1b u bolesnika s multiplom sklerozom

Gogić, Tina
University of Split
School of Medicine
Neurology

Cite this document

Gogić, T. (2017). Značajke liječenja interferonom beta 1a i 1b u bolesnika s multiplom sklerozom (Master's thesis). Split: University of Split, School of Medicine. Retrieved from https://urn.nsk.hr/urn:nbn:hr:171:005204

Gogić, Tina. "Značajke liječenja interferonom beta 1a i 1b u bolesnika s multiplom sklerozom." Master's thesis, University of Split, School of Medicine, 2017. https://urn.nsk.hr/urn:nbn:hr:171:005204

Gogić, Tina. "Značajke liječenja interferonom beta 1a i 1b u bolesnika s multiplom sklerozom." Master's thesis, University of Split, School of Medicine, 2017. https://urn.nsk.hr/urn:nbn:hr:171:005204

Gogić, T. (2017). 'Značajke liječenja interferonom beta 1a i 1b u bolesnika s multiplom sklerozom', Master's thesis, University of Split, School of Medicine, accessed 02 March 2024, https://urn.nsk.hr/urn:nbn:hr:171:005204

Gogić T. Značajke liječenja interferonom beta 1a i 1b u bolesnika s multiplom sklerozom [Master's thesis]. Split: University of Split, School of Medicine; 2017 [cited 2024 March 02] Available at: https://urn.nsk.hr/urn:nbn:hr:171:005204

T. Gogić, "Značajke liječenja interferonom beta 1a i 1b u bolesnika s multiplom sklerozom", Master's thesis, University of Split, School of Medicine, Split, 2017. Available at: https://urn.nsk.hr/urn:nbn:hr:171:005204

Please login to the repository to save this object to your list.